Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection

NCT03485638 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03485638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03485638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Prediction of Cetuximab-Induced Hypersensitivity Reactions Using Cetuximab Specific IgE Detection
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
November 4, 2016
Completion date
November 3, 2020
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head & neck squamous cell carcinoma, tumor disease including colorectal cancer